Clinical Trial 555

Birmingham, AL 35203

Study Summary:

Subjects with benign prostatic hypertrophy, not being benefited with current available therapy, will be given this novel injectable therapy and evaluate the benefits.

Qualified Participants Must:

• Subjects aged 45 to 75yrs inclusive
• Able to sign informed consent
• Have documented history of BPH for atleast one year
• Have stopped any BPH medications for atleast 30 days prior to recieving this novel therapy

Qualified Participants May Receive:

Compensated for time and travel.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.